$0.5500
At close: Feb 10, 7:15 PM EDT
$0.5500
0.000.00%
After Hours: Feb 10, 7:15 PM EDT
Comments
Loading...
Marinus Pharmaceuticals Inc COM NEW (NASDAQ:MRNS) Stock, Earnings Estimates, EPS, And Revenue
Marinus Pharmaceuticals Inc COM NEW reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 7
EPS Estimate
$-0.350
Quarterly Revenue Estimate
$10.59M
Annual Revenue
–
Analyze the earnings history of Marinus Pharmaceuticals Inc COM NEW using advanced sorting and filters.
Data brought to you by Benzinga APIs
Marinus Pharmaceuticals Inc COM NEW (MRNS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.42 | $-0.41 | -2.44 % |
| Q2 | 2024-08-13 | $-0.63 | $-0.59 | -6.78 % |
| Q1 | 2024-05-08 | $-0.68 | $-0.66 | -3.03 % |
| Q4 | 2024-03-05 | $-0.74 | $-0.62 | -19.4 % |
Marinus Pharmaceuticals Inc COM NEW (MRNS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $8.54M | $9.42M | -9.31 % |
| Q2 | 2024-08-13 | $8.06M | $9.49M | -15.1 % |
| Q1 | 2024-05-08 | $7.68M | $9.12M | -15.8 % |
| Q4 | 2024-03-05 | $7.19M | $8.01M | -10.2 % |
FAQ
When is Marinus Pharmaceuticals Inc COM NEW (NASDAQ:MRNS) reporting earnings?
Marinus Pharmaceuticals Inc COM NEW (MRNS) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Marinus Pharmaceuticals Inc COM NEW (NASDAQ:MRNS)?
The Actual EPS was $-0.42, which missed the estimate of $-0.41.
What were Marinus Pharmaceuticals Inc COM NEW’s (NASDAQ:MRNS) revenues?
The Actual Revenue was $8.5M, which missed the estimate of $9.4M.
Browse earnings estimates, EPS, and revenue on all stocks.